Fig. 5.
Investigating potential mechanisms of folate cycle activation during chronic stress in INS1E β cells.
(A) Diagram showing sources of NAD+ and serine for folate cycling activation. ADP, adenosine 5′-diphosphate; ATP, adenosine 5′-triphosphate; TCA, tricarboxylic acid; SHMT1, serine hydroxymethyltransferase 1; CH2-THF, 5,10-methylenetetrahydrofolate; P-pyruvate, 3-phosphohydroxypyruvate; P-serine, 3-phosphoserine. (B) Glucose stimulation of INS1E β cells transfected with Apollo-NADP+. Cells were treated with 100 μM NMN for 24 hours to elevate NAD+ levels. UK (50 μM) was added 1 hour before imaging to block NADP+ reduction by pyruvate cycling. (C) Carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP; 1 μM) stimulation of INS1E β cells transfected with Apollo-NADP+ at 1 or 15 mM glucose. UK (50 μM) was added 1 hour before imaging to block pyruvate cycling. (D) Serine stimulation (0.3 mM) of unstressed (0 μM TBM) and stressed (8 hours of 100 μM TBM) INS1E β cells transfected with Apollo-NADP+. Cells were pretreated with 1 mM asparagine for 1 hour before imaging to promote extracellular serine uptake. Imaging was done at low glucose (1 mM) to avoid activation of pyruvate cycling. (E) Serine stimulation (0.3 mM) of INS1E β cells transfected with Apollo-NADP+. Cells were treated with 100 μM NMN for 24 hours to elevate NAD+ levels or treated with both 100 μM NMN and 5 μM MTX for 24 hours to block NAD+ conversion to NADP+. One hour before imaging, cells were pretreated with 1 mM asparagine to promote extracellular serine uptake. Imaging was done at low glucose (1 mM) to avoid activation of pyruvate cycling. (F) Simplified diagram of potential factors required to trigger NADP+ reduction through folate cycling. n = 3 to 6 replicates. *P < 0.05, **P < 0.01, and ***P < 0.001.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Sci Adv
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.